Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Pediatric palliative care is a specialized medical care for infants and children living with serious medical conditions such as cancer, genetic disorders, prematurity, heart and lung conditions, neurologic disorders, and others. The goal of palliative care is to improve quality of life for both the child and the family by providing relief from the symptoms and stress of the illness.

Various drugs provided in the palliative care include analgesics, anti?emetics, laxatives, adjuvant medications, steroids, sedatives, neuroleptic medications, and others.

The global pediatric palliative care drugs market is estimated to be valued at US$ 71.8 billion in 2020 and is expected to exhibit a CAGR of 5.1% over the forecast period (2020-2027).

Figure 1. Global Pediatric Palliative Care Drugs Market Share (%) in Terms of Value, By Region, 2020

Pediatric Palliative Care Drugs  | Coherent Market Insights

Increasing number of rare diseases with pediatric onset is expected to propel the market growth over the forecast period

Increasing number of rare genetic diseases which have pediatric onset leads to an increased demand for pediatric palliative care drugs, which is expected to drive the market growth over the forecast period. According to an article published in the European Journal of Human Genetics in September 2019, out of 6,172 clinically unique rare diseases described in Orphanet, an international reference knowledge base for rare diseases and orphan drugs, around 3,510 (69.9%) diseases are exclusively pediatric onset and around 908 (18.2%) diseases have onset spanning both adults and pediatric groups.

request-sample

Pediatric Palliative Care Drugs Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 71.8 Bn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.1% 2027 Value Projection: US$ 101.8 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Drug Class: Analgesics, Anti?emetics, Laxatives, Adjuvant Medications, Steroids, Sedatives, Neuroleptic Medications, Others.
  • By Route of Administration: Oral, Topical, Parenteral.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Companies covered:

Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co., Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.

Growth Drivers:
  • Increasing number of rare diseases with pediatric onset
  • Increasing pediatric drugs product approvals by regulatory authorities
Restraints & Challenges:
  • Lack of awareness about palliative care

Increasing pediatric drugs product approvals by regulatory authorities is expected to drive the market growth over the forecast period

Market players are more focused on obtaining product approvals from regulatory authorities in order to expand their product portfolio in pediatric palliative care drugs market, which is expected to boost the market growth over the forecast period. For instance, in August 2018, Eisai Inc., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) expanded the indication of its antiepileptic drug, FYCOMPA, indicated for monotherapy and adjunctive use in patients of age 4 years and older for treating partial-onset seizures (POS). Eisai Inc. received approval from the U.S. FDA for both tablet and oral suspension formulations of FYCOMPA.

Global Pediatric Palliative Care Drugs Market – Impact of Coronavirus (Covid-19) Pandemic

The coronavirus disease (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) as a pandemic on March 11, 2020.

According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 34.8 million cases and more than 1 million deaths due to coronavirus disease (COVID-19) were reported on October 04, 2020 across the globe.

According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the coronavirus disease (COVID-19) cases in different regions reported on October 04, 2020 are as follows:

WHO Regions

New cases in last 7 days

Cumulative cases

The Americas

756,926

16,990,036

South-east Asia

614,502

7,335,273

Europe

478,119

6,187,384

Africa

26,208

1,198,550

Eastern Mediterranean

125,567

2,466,722

Western Pacific

24,751

625,642

COVID-19 has affected the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of products and raw materials from one place to another, which is expected to limit the market growth during the forecast period.

Pediatric Palliative Care Drugs Market: Restraints

However, lack of awareness about palliative care is expected to hinder growth of the global pediatric palliative care drugs market during the forecast period. According to the New Public Opinion Research from the Center to Advance Palliative Care (CAPC), August 2019, palliative care is relatively unknown among general public but with proper education about the palliative care, understanding and favorability might increase among consumers and physicians.

Key Players

Major players operating in the global pediatric palliative care drugs market include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co., Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.

Palliative care focuses on improving the quality of life of people who are suffering from chronic diseases such as kidney failure, amyotrophic lateral sclerosis (ALS), cancer, Parkinson’s, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), and others. Therefore, increasing prevalence of such diseases, especially cancer, is expected to drive growth of the pediatric palliative care drugs market over the forecast period. According to the Cancer Research UK, around 1,878 new cases of cancer in children were diagnosed from 2015 to 2017 in the U.K.

Market Dynamics

Market players are focusing on adopting various inorganic growth strategies such as acquisitions and agreements in order to enhance their product portfolio for rare and genetic diseases such as congenital adrenal hyperplasia (CAH) and strengthen their market presence. For instance, on March 27, 2020, Eton Pharmaceuticals, Inc, a pharmaceutical company, which focuses on development and commercialization of innovative drug products, announced the acquisition of the U.S. marketing rights for Alkindi Sprinkle, a neutral sprinkle (granule) formulation of hydrocortisone, developed by Diurnal Group plc, a U.K.-based pharmaceutical company. Alkindi Sprinkle is a replacement therapy for pediatric adrenal insufficiency (AI), including the genetic disorder congenital adrenal hyperplasia (CAH).

Key features of the study:

  • This report provides in-depth analysis of the global pediatric palliative care drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pediatric palliative care drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market

Detailed Segmentation:

  • Global Pediatric Palliative Care Drugs Market, By Drug Class:
    • Analgesics
    • Anti‐emetics
    • Laxatives
    • Adjuvant Medications
    • Steroids
    • Sedatives
    • Neuroleptic Medications
    • Others
  • Global Pediatric Palliative Care Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
  • Global Pediatric Palliative Care Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Pediatric Palliative Care Drugs Market, By Region:
    • North America
      • By Drug Class:
        • Analgesics
        • Anti‐emetics
        • Laxatives
        • Adjuvant Medications
        • Steroids
        • Sedatives
        • Neuroleptic Medications
        • Others
      • By Route of Administration
        • Oral
        • Topical
        • Parenteral
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies  
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Drug Class:
        • Analgesics
        • Anti‐emetics
        • Laxatives
        • Adjuvant Medications
        • Steroids
        • Sedatives
        • Neuroleptic Medications
        • Others
      • By Route of Administration
        • Oral
        • Topical
        • Parenteral
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Class:
        • Analgesics
        • Anti‐emetics
        • Laxatives
        • Adjuvant Medications
        • Steroids
        • Sedatives
        • Neuroleptic Medications
        • Others
      • By Route of Administration
        • Oral
        • Topical
        • Parenteral
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Class:
        • Analgesics
        • Anti‐emetics
        • Laxatives
        • Adjuvant Medications
        • Steroids
        • Sedatives
        • Neuroleptic Medications
        • Others
      • By Route of Administration
        • Oral
        • Topical
        • Parenteral
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Class:
        • Analgesics
        • Anti‐emetics
        • Laxatives
        • Adjuvant Medications
        • Steroids
        • Sedatives
        • Neuroleptic Medications
        • Others
      • By Route of Administration
        • Oral
        • Topical
        • Parenteral
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies  
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Class:
        • Analgesics
        • Anti‐emetics
        • Laxatives
        • Adjuvant Medications
        • Steroids
        • Sedatives
        • Neuroleptic Medications
        • Others
      • By Route of Administration
        • Oral
        • Topical
        • Parenteral
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Novartis International AG *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Amneal Pharmaceuticals, Inc.
    • Mallinckrodt Pharmaceuticals
    • Anqiu Lu'an Pharmaceutical Co., Ltd.
    • Granules India Limited
    • Zhejiang Kangle Pharmaceutical Co., Ltd.
    • Farmson Pharmaceutical Gujarat Pvt. Ltd.
    • Atabay Pharmaceutical Factory
    • Anhui Fubore Pharmaceutical & Chemical Co.,Ltd
    • Huzhou Konch Pharmaceutical Co., Ltd.
    • Alnylam Pharmaceuticals Inc.
    • Eton Pharmaceuticals, Inc
    • Eisai Inc.

“*” marked represents similar segmentation in other categories in the respective section.       

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • PEST Analysis
  4. Global Pediatric Palliative Care Drugs Market – Impact of Coronavirus (Covid-19) Pandemic
    • During-COVID 19 Market Analysis
    • Post-COVID 19 Market Analysis
    • Key Developments
  5. Global Pediatric Palliative Care Drugs Market, By Drug Class, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Anti‐emetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Laxatives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Adjuvant Medications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Steroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Sedatives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Neuroleptic Medications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Pediatric Palliative Care Drugs Market, By Route of Administration, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Pediatric Palliative Care Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Pediatric Palliative Care Drugs Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Class, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Novartis International AG
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mylan NV
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amneal Pharmaceuticals, Inc.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mallinckrodt Pharmaceuticals
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anqiu Lu'an Pharmaceutical Co., Ltd.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Granules India Limited
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Zhejiang Kangle Pharmaceutical Co., Ltd.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Farmson Pharmaceutical Gujarat Pvt. Ltd.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Atabay Pharmaceutical Factory
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Anhui Fubore Pharmaceutical & Chemical Co.,Ltd
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Huzhou Konch Pharmaceutical Co., Ltd.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Alnylam Pharmaceuticals Inc.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eton Pharmaceuticals, Inc
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eisai Inc.
        • Company Overview
        • Device Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 34 figures on "Pediatric Palliative Care Drugs Market” - Global forecast to 2027

Frequently Asked Questions

The global pediatric palliative care drugs market size is estimated to surpass US$ 101.8 billion by 2027.
The global pediatric palliative care drugs market is expected to register a CAGR of 5.1% during the forecast period (2020-2027).
Increasing number of rare diseases with pediatric onset and increasing pediatric drugs product approvals by regulatory authorities are driving the global pediatric palliative care drugs market growth.
The analgesics segment is estimated to hold major market share in 2020, owing to high prevalence of heart conditions in pediatric patients.
Major factor hampering growth of the market is lack of awareness about palliative care.
Major players operating in the global pediatric palliative care drugs market include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co., Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner